MCI-186 (edaravone)

edaravone · Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MCI-186 (edaravone), covering 2020-02-28 to 2025-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Dose Finding Study of MCI-186 in Acute Ischemic Stroke [Phase 2]